Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors.
Affiliation
Cell Therapy Group, Cancer Research UK Department of Medical Oncology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. dgilham@picr.man.ac.ukIssue Date
2010-02
Metadata
Show full item recordAbstract
BACKGROUND: HIV-1 fails to successfully infect mouse T cells as a result of several blocks in the viral replication cycle. We investigated whether this also impacted on the use of HIV-1 derived lentiviral vectors for stable gene transfer into mouse T cells. METHODS: Freshly isolated primary mouse T cells were immediately mixed with lentiviral vectors encoding an enhanced green fluorescent protein marker gene and transduction frequency was determined after 5 days of culture. RESULTS: Optimal transduction required both mouse T cell activation and cytokine support. Furthermore, transduction was also dependent upon the promoter chosen, with the rank order of potency being PGK > EF1 > SFFV > CMV. HIV-1 lentiviral vectors also efficiently transduced cytokine-stimulated T cells (in the absence of antibody driven T cell activation), albeit with a lower level of transgene expression compared to fully-activated T cells. CONCLUSIONS: The present study demonstrates that primary mouse T cells can be efficiently transduced with HIV-1 lentiviral vectors, opening up prospects for their use in mouse models of gene-modified adoptive cellular therapy.Citation
Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors. 2010, 12 (2):129-36 J Gene MedJournal
The Journal of Gene MedicineDOI
10.1002/jgm.1421PubMed ID
20033928Type
ArticleLanguage
enISSN
1521-2254ae974a485f413a2113503eed53cd6c53
10.1002/jgm.1421
Scopus Count
Collections
Related articles
- Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo.
- Authors: Park F, Kay MA
- Issue date: 2001 Sep
- Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
- Authors: Laurie KL, Blundell MP, Baxendale HE, Howe SJ, Sinclair J, Qasim W, Brunsberg U, Thrasher AJ, Holmdahl R, Gustafsson K
- Issue date: 2007 Dec
- Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
- Authors: Beutelspacher SC, Ardjomand N, Tan PH, Patton GS, Larkin DF, George AJ, McClure MO
- Issue date: 2005 Jun
- Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
- Authors: Schüle S, Steidl S, Panitz S, Coulibaly C, Kalinke U, Cichutek K, Schweizer M
- Issue date: 2006 Jul 20
- Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
- Authors: Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J
- Issue date: 2007 Jun 1